Bristol-Myers Squibb sees stabilizing sales, growth in key drugs, and raised guidance. Click to read more about why BMY is an ...

Looking ahead, revenue is expected to decline by 5.5% p.a. on average during the next 3 years, while revenues in the Pharmaceuticals industry in the US are expected to grow by 8.6%.

Bristol-Myers Squibb Company (NYSE:BMY) ranks among the best medical stocks to buy according to analysts. Bristol-Myers ...

President Donald Trump just sent letters to heads of 17 major pharmaceutical companies pushing them to drop drug prices in ...

Helped by higher advertising and a growing user base on its social media platforms, Meta earned $18.34 billion in the quarter ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...

September S&P 500 E-Mini futures (ESU25) are down -0.93%, and September Nasdaq 100 E-Mini futures (NQU25) are down -1.03% ...

Founder Lisa Pamintuan, President, Nicolas of Palm Beach Worldipi believes that this new patent will be a paradi ...

Equities extended their July advance, with the S&P 500 set for its longest streak of monthly gains since September.

More than 800 participants and over 100 teams have committed the community-led fundraiser Milwaukee –The Medical College of Wisconsin (MCW) Cancer Center’s inaugural Audaxity bike ride is uniting ...

Wall Street weighed a tariff reprieve for Mexico, new trade deal with South Korea, and strong earnings from Meta and ...